Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
59,119,327
-
Total 13F shares
-
41,992,032
-
Share change
-
-3,903,758
-
Total reported value
-
$532,719,965
-
Put/Call ratio
-
52%
-
Price per share
-
$12.69
-
Number of holders
-
108
-
Value change
-
-$34,781,330
-
Number of buys
-
61
-
Number of sells
-
49
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2015
As of 30 Jun 2015,
Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,992,032 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT CO, PAULSON & CO. INC., Palo Alto Investors, LLC, GOLDMAN SACHS GROUP INC, STATE STREET CORP, KINGDON CAPITAL MANAGEMENT, L.L.C., BlackRock Fund Advisors, MORGAN STANLEY, venBio Select Advisor LLC, and GREAT POINT PARTNERS LLC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.